
Patient monitoring specialist Masimo said the FDA has cleared smartSedLine, a brain function monitoring solution designed to help clinicians understand changes in a patient's response to anesthesia faster and more consistently.
The solution provides clinicians with information about brain activity including during induction and when electroencephalography (EEG) signals are low.
Masimo SedLine and smartSedLine help translate raw EEG signal data into more easily interpretable information through features such as Patient State Index (PSi) and Density Spectral Array (DSA). PSi uses multiple processing engines to analyze EEG power and patterns and compute a final PSi value that helps clinicians assess a patient's sedation state during anesthesia.
"Every patient responds differently to anesthesia, and understanding those individual responses is critical to optimizing depth of sedation and informing care," said Masimo Chief Medical Officer Dr. Basil Matta in a statement. "By providing clinicians with more responsive and stable information about brain activity, smartSedLine's faster PSi response allows clinicians to optimize anesthesia from induction throughout the intraoperative period. This earlier insight into a patient's sedation state makes it easier to provide individualized patient care, which may improve hemodynamic stability in high-risk patients and those with vulnerable brains. This is truly a novel approach to care."
With the new clearance, Masimo introduces the advanced smartSedLine PSi algorithm that provides clinically relevant performance improvements, including faster PSi induction response and increased stability under low-power EEG conditions. These improvements are designed to support more individualized patient care and better clinical outcomes, including for high-risk and elderly patients. The clearance marks the latest milestone in the evolution of brain function monitoring and reflects Masimo's focus on translating advances in science and technology into solutions designed to support clinicians and patient care.
The smartSedLine solution is available through a new smartSedLine module and a new smartSedLine EEG sensor. Like the previous SedLine module, the new smartSedLine module is plug-and-play when connected to a compatible monitor, such as Masimo Root. On the Root platform, O3 Regional Oximetry can be used alongside smartSedLine to provide a powerful Brain Health Platform. The complementary technologies work together to support a more complete view of brain health during perioperative care.






















